Square wave voltammetric determination of nitrofurantoin in pharmaceutical formulations on highly boron-doped diamond electrodes at different boron-doping contents

The influence of the boron-doping levels in boron-doped diamond film electrodes on the electrochemical response of nitrofurantoin (NFT) and the development of an electroanalytical procedure for NFT determination were investigated. The investigations were carried out using the techniques of cyclic voltammetry and square wave voltammetry on diamond film electrodes with different boron-doping levels (i.e., 5000, 10,000 and 20,000 mg L⁻¹). The level of boron-doping in the diamond film electrodes influenced the electrochemical reduction of NFT. The appropriate cyclic voltammetric response of NFT was obtained with Britton-Robinson buffer at pH 4 and for diamond films doped with 10,000 and 20,000 mg L⁻¹ of boron. These two films were selected for the development of the electroanalytical procedure. The use of square wave voltammetry with the optimized parameters demonstrated a good linear relationship between the peak current and the NFT concentration for a wide range of concentration. The lower limit of detection for the electrodes doped with 10,000 and 20,000 mg L⁻¹ of boron were 2.69 × 10⁻⁸ mol L⁻¹ (6.40 μg L⁻¹) and 8.15 × 10⁻⁹ mol L⁻¹ (1.94 μg L⁻¹), respectively, while the lower limits of quantification were 8.96 × 10⁻⁸ mol L⁻¹ (21.33 μg L⁻¹) and 2.72 × 10⁻⁸ mol L⁻¹ (6.47 μg L⁻¹), respectively. The applicability of the proposed procedure was tested using a commercial pharmaceutical formulation of NFT, and the results were compared with the procedure recommended by the British Pharmacopeia. The proposed procedure was sensitive, accurate and precise for analysis of NFT and did not require complex preparations or renovations of the electrode surface. This presents the advantage of eliminating mercury waste and minimizing the adsorptive problems related to the use of other electrodic solid surfaces.     

Exploiting sequential injection analysis with lab-on-valve and miniaturized potentiometric detection: Epinephrine determination in pharmaceutical products

Miniaturized potentiometric units were constructed, evaluated and incorporated in a SIA-LOV manifold in order to the control of pharmaceutical analysis. The method validation was done with ephinefrine determinations in commercial pharmaceutical products. The optimization procedures were directed at potential versus epinephrine concentration. This approach was achieved by selecting 60 cm of reactor and a flow rate of 11 μL s⁻¹ and injecting 78 μL of epinephrine standard solutions in a 1.0 × 10⁻³ mol L⁻¹ IO₄⁻ solution. A linear range was found for epinephrine concentrations between 2.0 × 10⁻⁴ and 2.5 × 10⁻³ mol L^−l with a slope of 35528 mV L mol^−l and r² = 0.997. Under these conditions the analytical results for the commercial pharmaceutical formulations of 0.908 and 0.454 mg mL⁻¹, respectively, with a R.S.D. of 0.34 for both, was obtained. Through down scaling periodate-selective electrode it was possible to benefit from the recognized advantages of the lab-on-valve sequential-injection based systems, namely regarding equipment portability, reduced consumption of the sample and the reagents and the reduction of effluent waste. Furthermore, the new periodate electrode configuration is easy to achieve in common laboratories and enables the implementation of low volume detection cell where the electrical noise, that is frequently presented in potentiometric based procedures, is significantly reduced.     

Determination of diclofenac in pharmaceutical preparations using a potentiometric sensor immobilized in a graphite matrix

The characteristics, performance, and application of an electrode, namely Pt|Hg|Hg₂(DCF)₂|graphite, where DCF stands for diclofenac ion, are described. This electrode responds to diclofenac with sensitivity of (58.1 ± 0.8) mV/decade over the range 5.0 × 10⁻⁵ to 1.0 × 10⁻² mol l⁻¹ at pH 6.5-9.0 and a detection limit of 3.2 × 10⁻⁵ mol l⁻¹. The electrode is easily constructed at a relatively low cost with fast response time (within 10-30 s) and can be used for a period of 5 months without any considerable divergence in potentials. The proposed sensor displayed good selectivity for diclofenac in the presence of several substances, especially concerning carboxylate and inorganic anions. It was used to determine diclofenac in pharmaceutical preparations by means of the standard additions method. The analytical results obtained by using this electrode are in good agreement with those given by the United States Pharmacopeia procedures.     

A multicommuted flow system for sequential spectrophotometric determination of hydrosoluble vitamins in pharmaceutical preparations

A multicommuted flow system is proposed for spectrophotometric determination of hydrosoluble vitamins (ascorbic acid, thiamine, riboflavine and pyridoxine) in pharmaceutical preparations. The flow manifold was designed with computer-controlled three-way solenoid valves for independent handling of sample and reagent solutions and a multi-channel spectrophotometer was employed for signal measurements. Periodic re-calibration as well as the standard addition method was implemented by using a single reference solution. Linear responses (r=0.999) were obtained for 0.500-10.0 mg l⁻¹ ascorbic acid, 2.00-50.0 mg l⁻¹ thiamine, 5.00-50.0 mg l⁻¹ riboflavine and 0.500-8.00 mg l⁻¹ pyridoxine. Detection limits were estimated as 0.08 mg l⁻¹ (0.5 μmol l⁻¹) ascorbic acid, 0.8 mg l⁻¹ (2 μmol l⁻¹) thiamine, 0.2 mg l⁻¹ (0.5 μmol l⁻¹) riboflavine and 0.1 mg l⁻¹ (0.9 μmol l⁻¹) pyridoxine at 99.7% confidence level. A mean sampling rate of 60 determinations per hour was achieved and coefficients of variation of 1% (n=20) were estimated for all species. The mean reagent consumption was 25-fold lower in relation to flow-based procedures with continuous reagent addition. Average recoveries between 95.6 and 100% were obtained for commercial pharmaceutical preparations. Results agreed with those obtained by reference methods at 95% confidence level. The flow system is suitable for application in quality control processes and in dissolution studies of vitamin tablets.     

Carbon and diamond paste microelectrodes based on Mn(III) porphyrins for the determination of dopamine

Three Mn(III) porphyrins were used for the design of carbon paste and diamond paste based microelectrodes, which were employed for the determination of dopamine in pharmaceutical and biological samples using differential pulse voltammetry (DPV). The limits of detection lie between 1.6 × 10⁻¹³ and 2.0 × 10⁻⁶ mol L⁻¹ while the sensitivities were between 230 pA μmol L⁻¹ and 3.24 μA mol L⁻¹. Dopamine was recovered reliable from pharmaceutical and biological samples in percentages higher than 91.00% and 92.00%, respectively. The surface of the microelectrodes can easily be renewed by simple polishing, obtaining a fresh surface ready for use in a new assay.     

Spectrophotometric determination of beryllium in water samples after micelle-mediated extraction preconcentration

A new micelle-mediated phase preconcentration method for preconcentration of ultra-trace quantities of beryllium as a prior step to its determination by spectrophotometry has been developed. Chrome Azurol S (CAS) and cetyltrimethylammonium bromide (CTAB) were used as chelating agent and cationic surfactant, respectively. The method evaluates and eliminates the blank bias error present in such procedures using mean centering of ratio spectra. This procedure gives more accurate results than the traditional approach using absorbance values against reagent blank. The optimal extraction and reaction conditions were studied and the analytical characteristics of the method (e.g., limit of detection, linear range, preconcentration and improvement factors) were obtained. Linearity was obeyed in the range of 0.9-18.0 ng mL⁻¹ (1.00 × 10⁻⁷-2.00 × 10⁻⁶ mol L⁻¹) of beryllium. The detection limit of the method is 0.51 ng mL⁻¹ (5.66 × 10⁻⁸ mol L⁻¹) of beryllium. The interference effect of some anions and cations was also tested. The method was applied to the determination of beryllium in spring water samples.     

Electroanalytical determination of estriol hormone using a boron-doped diamond electrode

A boron-doped diamond (BDD) electrode was used for the electroanalytical determination of estriol hormone in a pharmaceutical product and a urine sample taken during pregnancy by square-wave voltammetry. The optimized experimental conditions were: (1) a supporting electrolyte solution of NaOH at a pH of 12.0, and (2) a frequency of 20 Hz, a pulse height of 30 mV and a scan increment of 2 mV (for the square-wave parameters). The analytical curve was linear in the concentration range of 2.0 × 10⁻⁷ to 2.0 × 10⁻⁵ mol L⁻¹ (r = 0.9994), with a detection limit of 1.7 × 10⁻⁷ mol L⁻¹ and quantification limit of 8.5 × 10⁻⁷ mol L⁻¹. Recoveries of estriol were in the range of 98.6-101.0%, for the pharmaceutical sample, and 100.2-103.4% for the urine sample, indicating no significant matrix interference effects on the analytical results. The accuracy of the electroanalytical methodology proposed was compared to that of the radioimmunoassay method. The values for the relative error between the proposed and standard methods were −7.29% for the determination of estriol in the commercial product and −4.98% in a urine sample taken during pregnancy. The results obtained suggest a reliable and interesting alternative method for electroanalytical determination of estriol in pharmaceutical products and urine samples taken during pregnancy using a boron-doped diamond electrode.     

Flow-injection chemiluminescence determination of fluoroquinolones by enhancement of weak chemiluminescence from peroxynitrous acid

A flow-injection chemiluminescence (CL) method is described for the determination of fluoroquinolones including ciprofloxacin, norfloxacin and ofloxacin. The method is based on the enhancement by these compounds of the weak CL from peroxynitrous acid. The linear ranges are 1.0×10⁻⁷ to 1.0×10⁻⁵ mol l⁻¹ for ciprofloxacin and norfloxacin, and 3.0×10⁻⁷ to 3.0×10⁻⁵ mol l⁻¹ for ofloxacin, respectively. The detection limits (S/N=3) are 4.5×10⁻⁸ mol l⁻¹ ciprofloxacin, 5.9×10⁻⁸ mol l⁻¹ norfloxacin and 1.1×10⁻⁷ mol l⁻¹ ofloxacin, respectively. The proposed method was applied to the determination of fluoroquinolones in pharmaceutical preparations.     

Development of a gold nanoparticles based chemiluminescence imaging assay and its application

In this paper, a novel gold nanoparticles based protein immobilization method was designed. Biocomposites of gold nanoparticles and proteins were successfully coated on poly(methyl methacrylate) (PMMA) plates and polystyrene microtiter plates. The proteins could be immobilized on solid materials with high density and better bioactivity. Based on above design, chemiluminescence (CL) imaging assay for determination of H₂O₂ and recombinant human interleukin-6 (rHu IL-6) was developed. The linear range and the loading capability were greatly improved when compared with imaging assay performed with direct proteins immobilization. Under the selected experimental conditions, a linear relationship was obtained between the CL intensity and the concentration of H₂O₂ in the range of 1.0 × 10⁻⁶ to 1.0 × 10⁻⁴ mol L⁻¹, and rHu IL-6 in the range of 2.0-312.0 pg mL⁻¹. The detection limits were 2 × 10⁻⁷ mol L⁻¹ (3σ) for H₂O₂ and 0.5 pg mL⁻¹ for rHu IL-6 with relative standard deviation of 3.8% for 3.0 × 10⁻⁵ mol L⁻¹ H₂O₂, and 4.4% for 39.0 pg mL⁻¹ rHu IL-6. This method has been applied to the determination of rHu IL-6 in human serum with satisfactory results.     

Batch and hydrodynamic monitoring of vitamin C using novel periodate selective sensors based on a newly synthesized Ni(II)-Schiff bases complexes as a neutral receptors

A highly selective membrane electrodes based on a two newly synthesized nickel (II) Schiff bases, [NiL¹] and [NiL²] where L¹ and L² are N,N/bis(salicylaldehyde)4,5-dimethyl-1,2-phenylenediamine (H₂L¹) and N,N/bis(salicylaldehyde)4,5-dichloro-1,2-phenylenediamine (H₂L²) were used as a neutral carrier ionophores for static and hydrodynamic potentiometric mode of operations for the determination of periodate. Under static mode of operation, the sensors displayed a near-Nernstian slope of −66.1 ± 0.8 and −59.9 ± 1.1 mV decade⁻¹ of activity and detection limits to 5.2 × 10⁻⁶ and 7.3 × 10⁻⁶ mol L⁻¹ for the sensors based on [NiL¹] and [NiL²], respectively. Under hydrodynamic mode of operation (FIA), the slope of the calibration plot, limit of detection, and working linear range were −71.1 mVdecade⁻¹ of activity, 7.3 × 10⁻⁶ and 1.0 × 10⁻⁵ to 1.0 × 10⁻³ mol L⁻¹, respectively. The response time of the sensors in whole concentration ranges was very short (<10 s). The response of the sensors was independent on the pH range of 3-8. A tubular version was further developed and coupled to a flow injection system for ascorbic acid (AA) determination in beverages and pharmaceutical preparations. This approach was achieved by selecting a 50-cm reactor and an overall flow of 3 mL min⁻¹, and injecting volume 100 μL of AA standards in a 1.0 × 10⁻⁴ mol L⁻¹ IO₄⁻ solution. Under these conditions, a linearity range of 2-13 μg mL⁻¹, with a slope of 4.97 mV (mg/L)⁻¹ (r² = 0.9995), detection limit 0.9 mg L⁻¹ and a reproducibility of ±1.1 mV (n = 5) was recorded. This simple and inexpensive flow injection analysis manifold, with a good potentiometric detector, enabled the analysis of ∼50 samples h⁻¹ without requiring pretreatment procedures. An average recovery of 98.8% and a mean standard deviation of 1.3% were obtained.     

Determination of brominated phenols in water samples by on-line coupled isotachophoresis with capillary zone electrophoresis

A method for determination of nine brominated phenols as environmental risk compounds was developed by on-line coupled capillary isotachophoresis and capillary zone electrophoresis (ITP–CZE). For ITP step, 1 × 10⁻² mol L⁻¹ hydrochloric acid with 3 × 10⁻² mol L⁻¹ ammediol pH 9.1 was used as the leading electrolyte, and 3 × 10⁻² mol L⁻¹ β-alanine with 2 × 10⁻² mol L⁻¹ sodium hydroxide pH 10.05 was used as the terminating electrolyte. As the background electrolyte for CZE separation, 2.5 × 10⁻² mol L⁻¹ β-alanine with 2.5 × 10⁻² mol L⁻¹ lysine pH 9.6 was used. All electrolytes contained 0.05% or 0.1% (m/v) hydroxyethylcellulose to suppress the electroosmotic flow. UV detection at wavelength 220 nm was used. Detection limits in order of tens of nmol L⁻¹ were achieved. Good repeatability of migration times (less than 0.33% RSD) and good repeatability of peak areas (less than 7.19% RSD) at concentration level 5 × 10⁻⁸ mol L⁻¹ were observed. Developed ITP–CZE method was applied to determination of brominated phenols in spiked tap and river water samples.     

Sensitive and ultra-fast determination of arsenic(III) by gas-diffusion flow injection analysis with chemiluminescence detection

A novel chemiluminescence gas-diffusion flow injection system for the determination of arsenic(III) in aqueous samples is described. The analytical procedure involves injection of arsenic(III) samples and standards into a 0.3 mol L⁻¹ hydrochloric acid carrier stream which is merged with a reagent stream containing 0.2% (w/v) sodium borohydride and 0.015 mol L⁻¹ sodium hydroxide. Arsine, generated in the combined carrier/reagent donor stream, diffuses across the hydrophobic Teflon membrane of the gas-diffusion cell into an argon acceptor stream and then reacts with ozone in the flow-through chemiluminescence measuring cell of the flow system. Under optimal conditions, the method is characterized by a wide linear calibration range from 0.6 μg L⁻¹ to 25 mg L⁻¹, a detection limit of 0.6 μg L⁻¹ and a sample throughput of 300 samples per hour at 25 mg L⁻¹ and 450 samples per hour at 25 μg L⁻¹.     

A dispersive liquid-liquid microextraction procedure for determination of boron in water after ultrasound-assisted conversion to tetrafluoroborate

A novel, simple and green procedure is presented for the determination of boron. The method is based on ultrasound-assisted conversion of boron to tetrafluoroborate anion and the formation of an ion pair between BF₄⁻ and Astra Phloxine reagent (R), followed by dispersive liquid-liquid microextraction of the ion pair formed and subsequent UV-vis spectrophotometric detection. The conversion of boron to tetrafluoroborate anion is performed in an acidic medium of 0.9 mol L⁻¹ H₂SO₄ in the presence of 0.1 mol L⁻¹ F^- by means of 10 min of ultrasonication. The extraction of the ion pair formed between BF₄⁻ and R (1 × 10⁻⁴ mol L⁻¹ R) is carried out by dispersive liquid-liquid microextraction using 0.5 mL of amyl acetate (as extraction solvent), tetrachloromethane (as auxiliary solvent) and acetonitrile (as dispersive solvent) in a ratio of 1:1:2. The absorbance of the coloured extracts obeys Beer's law in the range 0.22-18.7 mg L⁻¹ of B(III) at 553 nm wavelength. The limit of detection calculated from a blank test (n = 10) based on 3 s is 0.015 mg L⁻¹ of B(III). The method was applied to the determination of boron in mineral waters.     

Quantification of N-acetylcysteine in pharmaceuticals using cobalt phthalocyanine modified graphite electrodes

Flow injection analysis (FIA) with amperometric detection was employed for the quantification of N-acetylcysteine (NAC) in pharmaceutical formulations, utilizing an ordinary pyrolytic graphite (OPG) electrode modified with cobalt phthalocyanine (CoPc). Cyclic voltammetry was used in preliminary studies to establish the best conditions for NAC analysis. In FIA-amperometric experiments the OPG-CoPc electrode exhibited sharp and reproducible current peaks over a wide linear working range (5.0 × 10⁻⁵-1.0 × 10⁻³ mol L⁻¹) in 0.1 mol L⁻¹ NaOH solution. High sensitivity (130 mA mol⁻¹ cm²) and a low detection limit (9.0 × 10⁻⁷ mol L⁻¹) were achieved using the sensor. The repeatability (R.S.D.%) for 13 successive flow injections of a solution containing 5.0 × 10⁻⁴ mol L⁻¹ NAC was 1.1%. The new procedure was applied in analyses of commercial pharmaceutical products and the results were in excellent agreement with those obtained using the official titrimetric method. The proposed amperometric method is highly suitable for quality control analyses of NAC in pharmaceuticals since it is rapid, precise and requires much less work than the recommended titrimetric method.     

Determination of bismuth and zinc in pharmaceuticals by first derivative UV-Visible spectrophotometry

A first order derivative spectrophotometric method has been developed for the simultaneous determination of bismuth and zinc by dithizone without time-consuming extraction step. The reactions of bismuth and zinc with dithizone in a three component solution prepared in water, acetone and n-propanol mixture have been investigated. These cations react with dithizone in this mixture at pH 5.0, forming coloured complex that is stable for at least 2 h. The linear range in D evaluation was between 3.0 × 10⁻⁶ and 1.8 × 10⁻⁵ mol l⁻¹ for Zn and 2.4 × 10⁻⁶ and 1.2 × 10⁻⁵ mol l⁻¹ for Bi. The limits of detection for the analytical procedure were found 0.05 mg l⁻¹ for both cations. The relative standard deviations for the determination of 0.5 mg l⁻¹ bismuth and 0.5 mg l⁻¹ zinc were 1.2 and 1.1%, respectively, for five determinations. The procedure is simple, rapid and reliable. This method was applied to the determination of bismuth and zinc in the pharmaceutical materials successfully. Good agreement was achieved between the results obtained by the proposed and comparative methods.     

A reagent-free method based on a photo-induced fluorimetry in a sequential injection system

According to the current demands of environmentally friendly analytical chemistry and with a view to achieving lower reagent consumption with improved analytical performance, an automatic methodology composed of a photoreactor and fluorimetric detection (λ_exc = 287 nm, λ_em = 378 nm) was developed. To this end, a sequential injection analysis (SIA) system was developed for indomethacin determination using ultra-violet (UV) light which promotes an increase in the fluorescence of indomethacin. This increase in sensitivity makes it possible to apply this methodology to a dissolution test and to determine indomethacin in pharmaceutical formulations.The calibration graph for indomethacin was linear between 4.10 × 10⁻⁶ and 9.00 × 10⁻⁵ mol L⁻¹and the detection limit was 1.23 × 10⁻⁶ mol L⁻¹. The method was proven to be reproducible with a R.S.D. < 5% and sampling rate of approximately 20 per hour. The potential effect of several compounds commonly used as excipients on analytical signals was studied and no interfering effect was observed. Statistical evaluation at the 95% confidence level showed good agreement between the results obtained for the pharmaceutical samples with both the SIA system and comparison batch procedures.     

Sensitive determination of captopril by time-resolved chemiluminescence using the stopped-flow analysis based on potassium permanganate oxidation

The chemiluminescent behaviour of captopril when reacted with a common oxidant, potassium permanganate in different acidic media is described, using the stopped-flow technique in a continuous-flow system. A 22 bit analogue-to-digital converter that acquires analogue signals at −10 and +10 V and allows the power supply to the peristaltic pump to be interrupted is used in the time-resolved chemiluminescence manifold to ensure rapid, efficient mixing of chemiluminescent reagent and sample immediately before reaching the detector; this results in high precision and detectability, particularly with fast, short-lived emissions.The optimum chemical conditions for the chemiluminescence emission were investigated. It was found that a weak CL emission was emitted during the oxidation of this drug with potassium permanganate in acidic solution. The effect of common emission enhancers such as formic acid, formaldehyde, glutaraldehyde, acetaldehyde, quinine, fluorescein, rhodamine B and rhodamine 6G was studied. The parameters selected were 4.0 mol L⁻¹ sulphuric acid, 0.25 mmol L⁻¹ permanganate and 0.75 mol L⁻¹ formaldehyde.Four quantitative parameters adjustable via software settings, two of them typically kinetic parameters, such as rate of the light-development reaction and rate of the light-decay reaction, and the other conventional parameters, such as maximum emission intensity and total emission area, were used to obtain linear calibration graphs with each measurement parameter. The detection limits ranged from 0.011 to 0.026 μg mL⁻¹ and R.S.D. values (n = 10) of 1.21-3.93 at a 0.50 μg mL⁻¹ and 2.01-3.41 at a 1.60 μg mL⁻¹ concentration levels were obtained. The method was satisfactorily applied to the determination of captopril in pharmaceutical preparations.     

Preliminary evaluation of monolithic column high-performance liquid chromatography with tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection for the determination of quetiapine in human body fluids

High-performance liquid chromatography (HPLC) with tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection methodology is reported for the determination of the atypical antipsychotic drug quetiapine and the observation of its major active and inactive metabolites in human urine and serum. The method uses a monolithic chromatographic column allowing high flow rates of 3 mL min⁻¹ enabling rapid quantification. Flow injection analysis (FIA) with tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection and HPLC time of flight mass spectrometry (TOF-MS) were used for the determination of quetiapine in a pharmaceutical preparation to establish its suitability as a calibration standard. The limit of detection achieved with FIA was 2 × 10⁻¹¹ mol L⁻¹ in simple aqueous solution. The limits of detection achieved with HPLC were 7 × 10⁻⁸ and 2 × 10⁻¹⁰ mol L⁻¹ in urine and serum, respectively. The calibration range for FIA was between 5 × 10⁻⁹ and 1 × 10⁻⁶ mol L⁻¹. The calibration ranges for HPLC were between 1 × 10⁻⁷-1 × 10⁻⁴ and 1 × 10⁻⁸-1 × 10⁻⁴ mol L⁻¹ in urine and serum, respectively. The quetiapine concentrations in patient samples were found to be 3 × 10⁻⁶ mol L⁻¹ in urine and 7 × 10⁻⁷ mol L⁻¹ in serum. Without the need for preconcentration, the HPLC detection limits compared favourably with those in previously published methodologies. The metabolites were identified using HPLC-TOF-MS.     

Determination of antihelminthic drug pyrantel pamoate in bulk and pharmaceutical formulations using electro-analytical methods

Electrochemical behaviour of pyrantel pamoate has been studied by using different voltammetric and polarographic techniques in Britton Robinson buffer system. Differential pulse polarographic and cyclic voltammetric methods have been developed for the determination of drug in pharmaceutical formulation. A well-defined cathodic wave and one anodic peak were observed for the pyrantel pamoate in the entire pH range. Number of electrons transferred in the reduction process was calculated and the reduction mechanism postulated. The results indicate that the electrode process is reversible and diffusion controlled. The proposed method has been validated. The peak current is found to be linear over the concentration range 4 × 10⁻⁴ to 2 × 10⁻² mol L⁻¹. The lower detection limit (LOD) and lower limit of quantitation (LOQ) is found to be 2.45 × 10⁻⁵ and 8 × 10⁻⁵ mol L⁻¹.     

Flow injection determination of thyroxine in pharmaceutical preparations using tris(2,2′-bipyridyl)ruthenium(III)-NADH chemiluminescence detection

A flow injection (FI) method is reported for the determination of thyroxine based on its enhancement of chemiluminescence (CL) from the Ru(bpy)₃³⁺-NADH system. The calibration graph was linear over the range 2.0-10 × 10⁻⁸ mol L⁻¹ (r² = 0.9989) with relative standard deviations (R.S.D.) in the range 2.0-4.5% (n = 4). The limit of detection (3σ blank) was 1.0 × 10⁻⁹ mol L⁻¹ with sample throughput of 120 h⁻¹. The effect of some organic compounds, anions and cations were studied for l-thyroxine determination. The method was applied to pharmaceutical preparations and the results obtained were in reasonable agreement with the amount labeled. The method was statistically compared with the results obtained by RIA; no significant disagreement at 95% confidence limit was observed. A calibration graph of NADH over the range 1.3 × 10⁻⁸-1.3 × 10⁻⁶ mol L⁻¹ was also established (r² = 0.9992) with R.S.D. in the range1.0-3.5% (n = 4). The limit of detection (3σ) was 1.0 × 10⁻¹⁰ mol L⁻¹ NADH.